People diagnosed with multiple myeloma—one of the most common forms of blood cancer—are now living nearly twice as long on average as they were in 2005, according to a new study. Subscribe to our ...

Add Yahoo as a preferred source to see more of our stories on Google. People with a form of blood cancer are living almost twice as long on average compared to 20 years ago, according to a study.

People with a rare and incurable form of blood cancer are living almost twice as long on average compared to 20 years ago, according to a study. However, experts warned survival for multiple myeloma ...

An innovative blood cancer treatment regime could extend remission by seven months on average, according to a clinical trial led by the University of Leeds. Myeloma, a blood cancer that accounts for 1 ...

Awareness Month, which raises awareness, action, and amplifies the voices of individuals impacted by MM, a blood cancer in which abnormal plasma cells build up in the bone marrow, producing large ...

People with limited English are significantly more likely to understand the true aim of cancer treatment when given a bilingual consent form, with understanding rising from 35% to 60%, a new study ...

Selinexor and dexamethasone is a treatment for myeloma. Find out about how you have it, possible side effects and other important information.

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. GSK’s blood cancer drug Blenrep won regulatory approval in the U.K. on ...

People with a form of blood cancer are living almost twice as long on average compared to 20 years ago, according to a study. However, experts warned survival for multiple myeloma “remains ...